[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.161.241.199. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
December 15, 2010

Antiretroviral Treatment for HIV-Infected Infants Exposed to Nevirapine

JAMA. 2010;304(23):2589-2590. doi:10.1001/jama.2010.1818

To the Editor: Dr Coovadia and colleagues1 reported on an innovative randomized controlled trial of 2 antiretroviral treatment (ART) strategies in nevirapine-exposed infants. The trial provided important new information regarding the option of switching to nevirapine-based ART after 3 months of viral suppression with lopinavir/ritonavir–based ART or continuing with the latter. In this study, the superior treatment strategy depended on whether virologic failure was defined by one plasma viral load greater than 50 copies/mL (the primary end point) or a confirmed viral load greater than 1000 copies/mL.

First Page Preview View Large
First page PDF preview
First page PDF preview
×